Monteverde & Associates PC, a top class action law firm, is investigating the proposed sale of Pacira BioSciences to Viatris Inc., where Pacira shareholders are set to receive $36.50 per share in cash. The firm is questioning whether this deal is fair to shareholders and offers free information and legal consultation to those affected. This investigation highlights potential shareholder concerns about the transaction's terms and the firm's track record in recovering money for shareholders.
The shareholder investigation of Pacira BioSciences is presented here with related market data for context. For readers following the health sector, 109 of 128 priced US health stocks on Pluang rose today while 18 fell. Notable movers include CRSP at USD 53.39 (+5.85%), INO at USD 1.15 (+5.50%), and BNTX at USD 96.96 (+5.32%). This data is as of Oct 11, 2026 20:21 WIB.
Freenome announced improved clinical validation results for its updated SimpleScreen™ CRC blood test, showing an 18.2% sensitivity for advanced precancerous lesions (APLs), up from 13.7% in the original test. Sensitivity for high-grade dysplasia APLs...
BridgeBio Pharma announced that encaleret, a treatment for autosomal dominant hypocalcemia type 1 (ADH1), increased bone turnover and improved patient-reported symptoms in the Phase 3 CALIBRATE trial. 100% of patients on encaleret reported symptom im...
Remittix announced its final presale price for the RTX token at $0.46, set as the minimum exchange launch price for its market debut on November 24, 2026. Currently, RTX is available at $0.23 during the ongoing presale stage, with the project nearing...
Block & Leviton is investigating Pasqal Holding for potentially misleading investors about its involvement in a French defense quantum-computing program. Pasqal announced ending its participation after the first phase, describing it as an "evolution"...
Injective (INJ) surged 10% amid increased buying pressure and notable exchange outflows, signaling renewed trader interest. Positive funding rates and rising open interest indicate bullish positioning, while ongoing ETF applications and an updated wh...
